Harry Clifford
As senior product architect in genomics at NVIDIA, Harry works at the interface between engineering and product development, leveraging NVIDIA’s expertise in AI, high performance computing (HPC), and data analytics stacks to address genomics workflows with accelerated high-accuracy solutions. His background is in bioinformatics and functional genomics, including a PhD from the University of Oxford, post-doctoral experience in the biopharma industry and at the University of Cambridge, and entrepreneurial experience in the biotech sector.
Harry was listed in Forbes’ “30 Under 30” after co-founding precision oncology company CCG.ai (acquired by Dante Labs), a Y Combinator and Merck Accelerator-backed start-up delivering decision support via deep learning and advanced analytical software.
